test

Harold Schaaff

@Soleus Capital Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ADPTAdaptive Biotechnologies Cor
Recent Activity
Decreased -35.3%
0.45%
$5.697M
1.113M shares@ $5.13 avg price
ALECAlector Inc
Recent Activity
Decreased -46.07%
0.44%
$5.626M
1.207M shares@ $4.67 avg price
YMABY-mabs Therapeutics Inc
Recent Activity
Decreased -38.27%
0.41%
$5.26M
399,982 shares@ $13.15 avg price
TMCITreace Med Concepts Inc
Recent Activity
Decreased -62.46%
0.4%
$5.15M
887,941 shares@ $5.81 avg price
BCABBioatla Inc
Recent Activity
Decreased -35.47%
0.35%
$4.431M
2.517M shares@ $1.76 avg price
DYNDyne Therapeutics Inc
Recent Activity
Decreased -41.54%
0.33%
$4.221M
117,500 shares@ $35.92 avg price
PODDInsulet Corp
Recent Activity
Decreased -10.9%
0.31%
$3.899M
16,750 shares@ $232.76 avg price
NARIInari Med Inc
Recent Activity
Decreased -77.01%
0.3%
$3.872M
93,878 shares@ $41.25 avg price
MREOMereo Biopharma Group Plc
Recent Activity
Decreased -32.07%
0.27%
$3.481M
846,953 shares@ $4.12 avg price
PCVXVaxcyte Inc
Recent Activity
Decreased -85.39%
0.24%
$3.091M
27,050 shares@ $114.28 avg price